MétaCan
Menu
← Back to cohort

S2890 A Global Perspective on Liver Cancer From Hyperglycemia: National and Regional Burden Based on the 2021 GBD Study

2025· article· en· W7114777685 on OpenAlexaboutno aff

Bibliographic record

VenueThe American Journal of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsYears of potential life lostLiver cancerCancerDisease burdenBurden of diseaseLatin AmericansConfidence intervalRisk factorMortality rate

Abstract

fetched live from OpenAlex

Introduction: Hyperglycemia has emerged as a significant and potentially modifiable risk factor for liver cancer, contributing to the rising global cancer burden. However, the extent of its impact at global, regional, and national levels remains insufficiently characterized. This study aims to comprehensively quantify the burden of liver cancer attributable to hyperglycemia by analyzing Disability-Adjusted Life Years (DALYs), mortality, and Years of Life Lost (YLLs) using data from the 2021 Global Burden of Disease (GBD) Study. Methods: We analyzed GBD 2021 data on liver cancer attributable to hyperglycemia from 1990 to 2021. Trends in age-standardized mortality, DALYs, and YLLs were assessed using Average Annual Percent Change (AAPC) with 95% confidence intervals (CIs). Results: Globally, hyperglycemia as a risk factor for liver cancer led to a total of 6.05 million DALYs). DALY rates increased from 1.73 per 100,000 in 1990 to 4.05 in 2021 (Average Annual Percentage Change [AAPC]: 2.82). A total of 265,302 deaths were attributed to hyperglycemia-related liver cancer, with mortality rates rising from 0.07 to 0.18 per 100,000 (AAPC: 3.17). Hyperglycemia contributed to 5.98 million YLLs, with YLL rates increasing from 1.71 to 4.01 per 100,000 over the study period (AAPC: 2.81). Regionally, the fastest rise in DALYs, mortality rates, and YLLs occurred in Australasia (AAPC: 6.38, 6.71, and 6.37, respectively), followed by Southern Latin America (AAPC: 5.87, 6.08, and 5.86) and High-income North America (AAPC: 5.73, 5.82, and 5.72). Nationally, the highest burden of DALYs, mortality rates, and YLLs was observed in Canada (7.11, 7.73, and 7.09 per 100,000, respectively), followed by Australia and Chile. In contrast, the greatest decline across all 3 metrics was documented in Mauritius. Conclusion: The global burden of liver cancer attributable to hyperglycemia has risen substantially over the past 3 decades, with the steepest increases observed in Australasia, Southern Latin America, and High-income North America. Nationally, Canada, Australia, and Chile faced the highest disease burden, while Mauritius showed a notable decline. These findings highlight critical geographic disparities and underscore the urgent need for targeted metabolic risk reduction strategies to curb the rising impact of hyperglycemia on liver cancer outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.071
Threshold uncertainty score0.142

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.006
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0100.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.313
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicLiver Disease Diagnosis and Treatment→French-language works237,207→